ScienceDex / Researcher record
Colevas, A. Dimitrios
- Beckman Research Institute/City of Hope (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2020 | $5,651,467 | 1 | #150 |
| 2023 | $1,594,203 | 1 | #5,291 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20201 record
- FY2023 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2020 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2023 award records by amount
NIH award records listing Colevas, A. Dimitrios as a PI. Multi-PI records show the full award amount for context.
- 4UM1CA186717-07UM1Contact PIPhase 1 and 2 Molecular and Clinical Pharmacodynamic Trials ETCTN$1.6Maward amount
Award organization
Organizations that administered FY2023 awards listing Colevas, A. Dimitrios as a PI.
FY2023 award administered by Beckman Research Institute/City of Hope (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2020First NIH AwardBeckman Research Institute/City of Hope
- 2020$500K Cumulative Funding
- 2020$1M Cumulative Funding
- 2020$2M Cumulative Funding
- 2020$5M Cumulative Funding
- 2020Entered Top 50% NationallyRanked #150
- 2020Entered Top 25% NationallyRanked #150
- 2020Entered Top 10% NationallyRanked #150
- 2020Entered Top 5% NationallyRanked #150
- 2020Entered Top 1% NationallyRanked #150